| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | STUDYID | DOMAIN | USUBJID | SESEQ | ETCD | ELEMENT | SESTDTC | SEENDTC |
|---|---|---|---|---|---|---|---|---|---|
| IG33_DM_SE_001 | ABC | SE | 001 | 1 | SCRN | Screen | 2006-06-01 | 2006-06-07 | |
| IG33_DM_SE_001 | ABC | SE | 001 | 2 | RI | Run-In | 2006-06-07 | 2006-06-21 | |
| IG33_DM_SE_001 | ABC | SE | 001 | 3 | A | Drug A | 2006-06-21 | 2006-07-05 | |
| IG33_DM_SE_001 | ABC | SE | 002 | 1 | SCRN | Screen | 2006-05-03 | 2006-05-10 | |
| IG33_DM_SE_001 | ABC | SE | 002 | 2 | RI | Run-In | 2006-05-10 | 2006-05-24 | |
| IG33_DM_SE_001 | ABC | SE | 002 | 3 | B | Drug B | 2006-05-24 | 2006-06-07 | |
| IG33_DM_SE_001 | ABC | SE | 003 | 1 | SCRN | Screen | 2006-06-27 | 2006-06-30 | |
| IG33_DM_SE_001 | ABC | SE | 004 | 1 | SCRN | Screen | 2006-05-14 | 2006-05-21 | |
| IG33_DM_SE_001 | ABC | SE | 004 | 2 | RI | Run-In | 2006-05-21 | 2006-05-26 | |
| IG33_DM_SE_001 | ABC | SE | 005 | 1 | SCRN | Screen | 2006-05-14 | 2006-05-21 | |
| IG33_DM_SE_001 | ABC | SE | 005 | 2 | RI | Run-In | 2006-05-21 | 2006-05-26 |
| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | STUDYID | DOMAIN | USUBJID | SESEQ | ETCD | ELEMENT | SESTDTC | SEENDTC |
|---|---|---|---|---|---|---|---|---|---|
| IG33_DM_SE_002 | DEF | SE | 001 | 1 | SCRN | Screen | 2006-01-07 | 2006-01-12 | |
| IG33_DM_SE_002 | DEF | SE | 001 | 2 | DBA | Treatment A | 2006-01-12 | 2006-04-10 | |
| IG33_DM_SE_002 | DEF | SE | 001 | 3 | OA | Open Drug A | 2006-04-10 | 2006-07-05 | |
| IG33_DM_SE_002 | DEF | SE | 002 | 1 | SCRN | Screen | 2006-02-03 | 2006-02-10 | |
| IG33_DM_SE_002 | DEF | SE | 002 | 2 | DBA | Treatment A | 2006-02-10 | 2006-03-24 | |
| IG33_DM_SE_002 | DEF | SE | 003 | 1 | SCRN | Screen | 2006-02-22 | 2006-03-01 | |
| IG33_DM_SE_002 | DEF | SE | 003 | 2 | DBB | Treatment B | 2006-03-01 | 2006-06-27 | |
| IG33_DM_SE_002 | DEF | SE | 003 | 3 | RSC | Rescue | 2006-06-27 | 2006-09-24 |
| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | STUDYID | DOMAIN | USUBJID | SESEQ | ETCD | ELEMENT | SESTDTC | SEENDTC | TAETORD | EPOCH |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-001 | 1 | SCREEN | Screen | 2016-02-02 | 2016-02-14 | 1 | SCREENING | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-001 | 2 | DRUG1 | Drug-1 | 2016-02-14 | 2016-03-14 | 2 | TREATMENT 1 | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-001 | 3 | DG1INDG | Drug 1 + Investigational Drug | 2016-03-14 | 2016-04-24 | 3 | TREATMENT 2 | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-001 | 4 | FU | Follow-up | 2016-04-24 | 2016-04-24 | 4 | FOLLOW-UP | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-002 | 1 | SCREEN | Screen | 2016-02-04 | 2016-02-21 | 1 | SCREENING | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-002 | 2 | DRUG2 | Drug-2 | 2016-02-21 | 2016-03-24 | 2 | TREATMENT 1 | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-002 | 3 | DG2INDG | Drug 2 + Investigational Drug | 2016-03-24 | 2016-04-29 | 3 | TREATMENT 2 | |
| IG33_DS_SE_010 | XYZ | SE | XYZ-767-002 | 4 | FU | Follow-up | 2016-04-29 | 2016-04-29 | 4 | FOLLOW-UP |
| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | STUDYID | DOMAIN | USUBJID | SESEQ | ETCD | SESTDTC | SEENDTC | SEUPDES | TAETORD | EPOCH |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IG33_DS_SE_011 | DS10 | SE | 101 | 1 | SCRN | 2015-01-21 | 2015-02-01 | 0 | SCREENING | ||
| IG33_DS_SE_011 | DS10 | SE | 101 | 2 | ABC | 2015-02-01 | 2015-03-01 | 1 | TREATMENT | ||
| IG33_DS_SE_011 | DS10 | SE | 101 | 3 | ABC | 2015-03-01 | 2015-03-29 | 2 | TREATMENT | ||
| IG33_DS_SE_011 | DS10 | SE | 101 | 4 | AB | 2015-03-29 | 2015-04-26 | 6 | TREATMENT | ||
| IG33_DS_SE_011 | DS10 | SE | 101 | 5 | FU | 2015-04-26 | 2015-09-19 | 8 | FOLLOW-UP |
| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | USUBJID | SESEQ | ETCD | SESTDTC | SEENDTC | SEUPDES | TAETORD | EPOCH |
|---|---|---|---|---|---|---|---|---|---|
| IG33_SE_SE_001 | 789 | 1 | SCREEN | 2006-06-01 | 2006-06-03T10:32 | 1 | SCREENING | ||
| IG33_SE_SE_001 | 789 | 2 | IV | 2006-06-03T10:32 | 2006-06-10T09:47 | 2 | TREATMENT 1 | ||
| IG33_SE_SE_001 | 789 | 3 | ORAL | 2006-06-10T09:47 | 2006-06-17 | 3 | TREATMENT 2 | ||
| IG33_SE_SE_001 | 789 | 4 | FOLLOWUP | 2006-06-17 | 2006-06-17 | 4 | FOLLOW-UP | ||
| IG33_SE_SE_001 | 790 | 1 | SCREEN | 2006-06-01 | 2006-06-03T10:14 | 1 | SCREENING | ||
| IG33_SE_SE_001 | 790 | 2 | IV | 2006-06-03T10:14 | 2006-06-10T10:32 | 3 | TREATMENT 1 | ||
| IG33_SE_SE_001 | 790 | 3 | ORAL | 2006-06-10T10:32 | 2006-06-17 | 2 | TREATMENT 2 | ||
| IG33_SE_SE_001 | 790 | 4 | FOLLOWUP | 2006-06-17 | 2006-06-17 | 4 | FOLLOW-UP | ||
| IG33_SE_SE_001 | 791 | 1 | SCREEN | 2006-06-01 | 2006-06-03T10:17 | 1 | SCREENING | ||
| IG33_SE_SE_001 | 791 | 2 | IV | 2006-06-03T10:17 | 2006-06-7 | 3 | TREATMENT 1 |
| Copyright @ www.statschoice.com |
| EXAMPLE_NUM | ROW_DESCRIPTION | USUBJID | SESEQ | ETCD | SESTDTC | SEENDTC | SEUPDES | TAETORD | EPOCH |
|---|---|---|---|---|---|---|---|---|---|
| IG33_SE_SE_002 | 123 | 1 | SCRN | 2006-06-01 | 2006-06-03 | 1 | SCREENING | ||
| IG33_SE_SE_002 | 123 | 2 | DBA | 2006-06-03 | 2006-06-10 | 2 | BLINDED TREATMENT | ||
| IG33_SE_SE_002 | 456 | 1 | SCRN | 2006-05-01 | 2006-05-03 | 1 | SCREENING | ||
| IG33_SE_SE_002 | 456 | 2 | DBA | 2006-05-03 | 2006-05-31 | 2 | BLINDED TREATMENT | ||
| IG33_SE_SE_002 | 456 | 3 | UNPLAN | 2006-05-31 | 2006-06-13 | Drug B dispensed in error | BLINDED TREATMENT | ||
| IG33_SE_SE_002 | 456 | 4 | RSC | 2006-06-13 | 2006-07-30 | 3 | OPEN LABEL TREATMENT |